AAAAAA

   
Results: 1-10 |
Results: 10
Antithrombotic therapy in the acute phase: New approaches
Authors: Sherman, DG
Citation: Dg. Sherman, Antithrombotic therapy in the acute phase: New approaches, CEREB DIS, 11, 2001, pp. 49-54
Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association
Authors: Goldstein, LB Adams, R Becker, K Furberg, CD Gorelick, PB Hademenos, G Hill, M Howard, G Howard, VJ Jacobs, B Levine, SR Mosca, L Sacco, RL Sherman, DG Wolf, PA del Zoppo, GJ
Citation: Lb. Goldstein et al., Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association, STROKE, 32(1), 2001, pp. 280-299
Use of anti-ICAM-1 therapy in ischemic stroke - Results of the Enlimomab Acute Stroke Trial
Authors: Sherman, DG Bes, A Easton, JD Hacke, W Kaste, M Polmar, SH Zivin, JA Fieschi, C Miller, P Schoenfeld, D Street, J Albers, G Atkinson, R Biller, J Bruno, A Carpenter, D Clark, W DeGraba, T Driscoll, P Ellis, J Greenlee, R Hess, D Horowitz, DR Davenport, J Hsu, C Starkman, S Madden, K Pettigrew, C Rosenbaum, D Schim, J Tietjen, G Mansbach, H Edwards, K Webb, R Crisostomo, E Wilterdink, J Rothrock, J Zweifler, R Dexter, J Horowitz, S Futrell, N Alter, M Schneider, D Ferbert, A Hacke, W Prange, H Wiersbitzky, M Buttner, T Schwartz, A Busse, O Klingelhofer, J Kaste, M Erila, T Sivenius, J Sotaniemi, K Liukkonen, J Hedman, C Muuronen, A Rissanen, A Bes, A Feve, JR Mahagne, MH Rancurel, G Trouillas, P Weber, M Thomassen, L Johnsen, HJ Kjallman, L Petersson, J Ferrari, G Lagi, A Mamoli, A Re, G
Citation: Dg. Sherman et al., Use of anti-ICAM-1 therapy in ischemic stroke - Results of the Enlimomab Acute Stroke Trial, NEUROLOGY, 57(8), 2001, pp. 1428-1434
Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association
Authors: Goldstein, LB Adams, R Becker, K Furberg, CD Gorelick, PB Hademenos, G Hill, M Howard, G Howard, VJ Jacobs, B Levine, SR Mosca, L Sacco, RL Sherman, DG Wolf, PA del Zoppo, GJ
Citation: Lb. Goldstein et al., Primary prevention of ischemic stroke - A statement for healthcare professionals from the Stroke Council of the American Heart Association, CIRCULATION, 103(1), 2001, pp. 163-182
Outcomes of ancrod in acute ischemic stroke - Reply
Authors: Sherman, DG Levy, DE
Citation: Dg. Sherman et De. Levy, Outcomes of ancrod in acute ischemic stroke - Reply, J AM MED A, 284(15), 2000, pp. 1927-1927
Intravenous ancrod for treatment of acute ischemic stroke - The STAT study: A randomized controlled trial
Authors: Sherman, DG Atkinson, RP Chippendale, T Levin, KA Ng, K Futrell, N Hsu, CY Levy, DE
Citation: Dg. Sherman et al., Intravenous ancrod for treatment of acute ischemic stroke - The STAT study: A randomized controlled trial, J AM MED A, 283(18), 2000, pp. 2395-2403
Abciximab in acute ischemic stroke - A randomized, double-blind, placebo-controlled, dose-escalation study
Authors: Adams, HP Bogousslavsky, J Barnathan, E Brott, T Fisher, M Furlan, AJ Graffagnino, C Kappelle, J Kothari, R Leclerc, JR Moulin, T Polzer, J Torner, J Worley, S Haley, CE Day, JH Levine, SR Thompson, JLP Sherman, DG Sane, DC Maley, JE Grimsman, KJ Maeder, M Clarke, WR Anderson, K Cook, R FitzPatrick, S Peeters, A Cras, P Blecic, S Laloux, P Chatel, M Mahagne, H Moulin, T Hacke, W Diener, HC Bogousslavsky, J Maeder, M Kappelle, LJ Vermulen, M Kwa, VIH Franke, CL Jacoby, M Libman, R Hsu, C Kothari, R Raps, EC Kasner, SE Scott, P Karanjia, P Heiselman, D Graffagnino, C Graham, G Akins, PT Brott, T Meschia, J Furlan, AJ Gordon, D Jackson, CM Starkman, S Wityk, R Worley, S Adams, HP Belden, JR Dashe, J Fisher, M Gomez, C Hwang, TL Jichici, D Thompson, D Adams, HP Barnathan, E Bogousslavsky, J Brott, T Fisher, M Furlan, AJ Hacke, W Kappelle, J Kothari, R Leclerc, JR Moulin, T Polzer, J Scott, P Torner, J
Citation: Hp. Adams et al., Abciximab in acute ischemic stroke - A randomized, double-blind, placebo-controlled, dose-escalation study, STROKE, 31(3), 2000, pp. 601-609
Phase II studies of the glycine antagonist GV150526 in acute stroke - The North American experience
Authors: Babikian, V Licata-Gehr, E Joseph, LN Bailey, P Boyle, R MacDougall, A MacLean, G Wheelock, WB Kolyvas, G Banas, T Wissman, MA Heckaman, JD Porter, MA Bhat, MH Later, PE Wissmann, SD Ottinger, CJ Stevens, JC Plant, R Chang, FL Beatty, J Beatty, TW Cohen, SB Vasquez, AB Schmidt, DW Allen, T Bellavance, A Hebert, L Berger, L Filatrault, R Nasredding, Z Trottier, AG Duplessis, M Maison, FG Ninkovic, S Berman, B Yipelkonen, M Miskin, BM Shaivitz, SA Benavente, O Bruce, G Solomen, D Sherman, D Hart, R Kanter-Carolin, M Lalonde, DR Rogers, D Bruce, G Leonard, A Brott, T Spilker, J Broderick, J Kothari, R Panicoli, A Sauerbeck, L Miller, R Clark, WM Deely, SM Fisher, S Lutsep, H Quinn, J Crawford, J Egan, R Nesbit, G Al-Azzaz, A Earley, C Herr, M Michel, H Dike, G Maragakis, N Polydefkis, M Wagner, K Wang, M Rusa, R Jones, C Kerr, D Moo, L Pardo, C Silverman, I Hoffman, J Diebert, E Jinnah, H York, J Hoke, A Vega-Bermudez, F Comi, A Hillis, A Rich, J Ervin, J Bryan, C Allen, AA Kelley, GB Perll, MF Box, MS Robles, LH Zwibelman, JS Hopewell, DK Ryan, ME Wendland, RT Feinberg, W Coull, B Rose-Taylor, D Ahern, G Anderson, LR Keim, S Sherman, S Rose-Taylor, D Haley, EC Morris, A Ahern, K Johnston, K Solenski, N Nathan, B Bleck, T Worrall, B Leszczyszyn, D Hemstreet, M Kiely, J Burns, T Klein, C Cail, W Huff, S Quinn, J Armstrong, R Provencio, J Snider, R Van Gerpen, J Hsu, C Duke, L Banet, G Choi, J Lee, JM Lowenkopf, T Innes, G Metcalf, C Huang, P Rumball, C Miller, B Haegert, J Holmes, A Oldring, B MacNab, J Grosch, R Deady, B Street, R O'Brien, R Vertesi, L Erhardt, G Finkler, J Tessler, C Glazer, S Noseworthy, R Knazen, M MacDonald, P Smyth, A Karp, J Phillips, B Spiegel, A Bowman, SC Hampsey, JP Habib, MW Schroeder, T Stopnytsky, K Kertecz, A Piotrowski, S Cooper, P Lyden, P Rapp, K Jackson, C Ellis, R Noack, H Sabbagh, M Galasko, D Rapp, K Kelly, N Werner, J Chang, CL Morris, DT Pusek, S Hinn, A Ma, J Bernard, E Phillips, S Reidy, Y Gubitz, G Tanha, F Leckey, R Ansell, J Darvesh, S Aguilar, E Pullicino, P Starr, S Munschauer, FE Ross, DB Norris, D Steinberg, J Zaret, B Maniar, M Sacco, RL Boden-Albala, B Jimenez, M Mohr, JP Kargman, D Marshall, R Elkind, MS Roberts, K Gan, R Shipley, N Aboumatar, S Greene, R Shuaib, A Kadribasic, E Keegan, M Stewart, B Khaan, K Shuaib, A Dean, TR Richardson, P Moussavian, M Faloriji, W Johnson, M Levin, Z Silliman, S Fuqua, PS Berger, A Najjar, S Schwartz, R Solomon, DH Limon, L Hart, RG Sherman, DG Carolin, MCK Lalonde, DR Benavente, O Starkman, S Schubert, GB Dobkin, B Saver, J Vespa, P Alger, J Teitelbaum, J Lachance, N Robillard, A Lachapelle, J Boileau, J Rousseau, S Roy, L Laplante, P Thurston, S McGee, JR Lutz, MA McGee, FE Harris, JK White, RJ O'Bannon, JM Brush, JJ Cohen, RJ Smith, TA Mathe, SA Karner, SF Worthington, AK Deel, JG Tong, D Hock, N Albers, G O'Brien, M Woofenden, A Yenari, M Freyberg, S Guro, G Hock, N Tuhrim, S Augustine, S Weinberger, J Horowitz, D Sheinart, K Schonewille, W Atlas, S Veloso, F Reid, M Adaikari, K Gebhardt, V Nair, CPV Wang, D Vrabel, D McLean, J Kumar, J Garwacki, D Roda, M Hui, E Coyner, J Vrabel, D Honings, D Rose, J Sladana, R Wechsler, L Yasko, L Knepper, L Massaro, L Graham, S Larkin, G Ulicny, T Yonas, H Barch, C Lin, H Brader, E Berkey, K Ludovici, J Kaufmann, A De Cesare, S Hodgdon, A MacLeod, B Thompson, D Piatkowski, S O'Toole, K Yasko, L Ilkhanipour, K Maenza, R Mathias, S Thulborn, K Jungreis, C Cockley, P Corsello, G Ammon, C Rasheed, A Weston, L Bourque, G Silverberg, D Harper, B Robinson, D MacEachern, M Williams, AD Roth, R Rice, M Hogan, J Pellegrino, TR Holland, MT Lanoue, RJ Redding, A Handler, J Haley, EC Alves, WM Elder, L Davenport, K McClure, K Knowlton, S Cuccia, E Maupin, K Lotts, M Hund, M Shelleck, K Szewc, T Cail, W Wagner, G Gates, K Earley, C Haley, EC Johnston, KC Sacco, RL Schuaib, A Snipes, R Wang, DZ Brass, LM Clark, WR Grotta, JC Harrison, M McIntyre, N Zimmerman, H Wellcome, G Snipes, R Watson, D Ordronneau, P Hoke, F Ko, WJ Clayton, L EnneyO' Mara, L Johnson, J Orander, C Card, B Green, S
Citation: V. Babikian et al., Phase II studies of the glycine antagonist GV150526 in acute stroke - The North American experience, STROKE, 31(2), 2000, pp. 358-365
Atrial fibrillation
Authors: Sherman, DG
Citation: Dg. Sherman, Atrial fibrillation, PREVENTION OF ISCHEMIC STROKE, 2000, pp. 137-145
Clinical trials for stroke: Design considerations
Authors: Sherman, DG Benavente, O
Citation: Dg. Sherman et O. Benavente, Clinical trials for stroke: Design considerations, STROKE THERAPY, 1999, pp. 339-353
Risultati: 1-10 |